These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38559571)

  • 1. Qualitative experiences, values, and decisional needs of patients with unprovoked venous thromboembolism who suffer bleeding-"This pill will keep you alive tonight".
    de Winter MA; Xu Y; Stacey D; Wells PS
    Res Pract Thromb Haemost; 2024 Feb; 8(2):102360. PubMed ID: 38559571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
    Robertson L; Yeoh SE; Ramli A
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciding on Treatment Duration for Unprovoked Venous Thromboembolism: What is Important to Patients?
    van de Brug A; de Winter MA; Ten Wolde M; Kaasjager K; Nijkeuter M
    Thromb Haemost; 2022 Apr; 122(4):600-610. PubMed ID: 34169494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Cost-Effectiveness Study.
    Khan F; Coyle D; Thavorn K; van Katwyk S; Tritschler T; Hutton B; Le Gal G; Rodger MA; Fergusson DA
    Ann Intern Med; 2023 Jul; 176(7):949-960. PubMed ID: 37364263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol.
    Khan F; Kimpton M; Tritschler T; Le Gal G; Hutton B; Fergusson DA; Rodger MA
    Syst Rev; 2019 Oct; 8(1):245. PubMed ID: 31661033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
    Marik PE; Cavallazzi R
    PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended anticoagulation for venous thromboembolism: A survey of the American Venous Forum and the European Venous Forum.
    Shaydakov ME; Ting W; Sadek M; Aziz F; Diaz JA; Comerota AJ; Lurie F; Blebea J; Eklöf BG; Lugli M; De Maeseneer MGR; Kakkos SK; Nicolaides A; Heim D; Welch HJ;
    J Vasc Surg Venous Lymphat Disord; 2022 Sep; 10(5):1012-1020.e3. PubMed ID: 35561974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which patients with unprovoked venous thromboembolism should receive extended anticoagulation with direct oral anticoagulants? A systematic review, network meta-analysis, and decision analysis.
    Djulbegovic M; Lee AI; Chen K
    J Eval Clin Pract; 2020 Feb; 26(1):7-17. PubMed ID: 31190408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on extended treatment for venous thromboembolism.
    Peñaloza-Martínez E; Demelo-Rodríguez P; Proietti M; Soria Fernández-Llamazares G; Llamazares-Mendo C; Álvarez-Sala Walther L; Marra AM; Del Toro-Cervera J
    Ann Med; 2018 Dec; 50(8):666-674. PubMed ID: 30345825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
    Khan F; Tritschler T; Kimpton M; Wells PS; Kearon C; Weitz JI; Büller HR; Raskob GE; Ageno W; Couturaud F; Prandoni P; Palareti G; Legnani C; Kyrle PA; Eichinger S; Eischer L; Becattini C; Agnelli G; Vedovati MC; Geersing GJ; Takada T; Cosmi B; Aujesky D; Marconi L; Palla A; Siragusa S; Bradbury CA; Parpia S; Mallick R; Lensing AWA; Gebel M; Grosso MA; Thavorn K; Hutton B; Le Gal G; Fergusson DA; Rodger MA;
    Ann Intern Med; 2021 Oct; 174(10):1420-1429. PubMed ID: 34516270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of DVT: how long is enough and how do you predict recurrence.
    Agnelli G; Becattini C
    J Thromb Thrombolysis; 2008 Feb; 25(1):37-44. PubMed ID: 17906973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
    Khan F; Tritschler T; Kimpton M; Wells PS; Kearon C; Weitz JI; Büller HR; Raskob GE; Ageno W; Couturaud F; Prandoni P; Palareti G; Legnani C; Kyrle PA; Eichinger S; Eischer L; Becattini C; Agnelli G; Vedovati MC; Geersing GJ; Takada T; Cosmi B; Aujesky D; Marconi L; Palla A; Siragusa S; Bradbury CA; Parpia S; Mallick R; Lensing AWA; Gebel M; Grosso MA; Shi M; Thavorn K; Hutton B; Le Gal G; Rodger M; Fergusson D
    J Thromb Haemost; 2021 Nov; 19(11):2801-2813. PubMed ID: 34379859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
    Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
    Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register.
    Palareti G; Legnani C; Antonucci E; Cosmi B; Falanga A; Poli D; Mastroiacovo D; Pengo V; Ageno W; Testa S
    Ther Adv Drug Saf; 2021; 12():20420986211062965. PubMed ID: 34987749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of strategies for restarting anticoagulation therapy after a first event of unprovoked venous thromboembolism.
    Monahan M; Ensor J; Moore D; Fitzmaurice D; Jowett S
    J Thromb Haemost; 2017 Aug; 15(8):1591-1600. PubMed ID: 28520199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis.
    Khan F; Rahman A; Tritschler T; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Pinede L; Parpia S; Geersing GJ; Takada T; Bradbury CA; Andreozzi GM; Palareti G; Prandoni P; Buller HR; Mallick R; Hutton B; Thavorn K; Le Gal G; Rodger MA; Fergusson DA
    Thromb Haemost; 2022 Jul; 122(7):1186-1197. PubMed ID: 34753191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project.
    Bortoluzzi C; Bernardi E; Camporese G; Noventa F; Ceccato D; Tonello C; Vo Hong N; Campello E; Simion C; Imbalzano E; Di Micco P; Callegari E; Simioni P
    Life (Basel); 2022 Oct; 12(10):. PubMed ID: 36295091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.
    Forster R; Stewart M
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD004179. PubMed ID: 27027384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated.
    Kearon C
    J Thromb Thrombolysis; 2011 Apr; 31(3):295-300. PubMed ID: 21331558
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.